Summitview Investment Management’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Summitview Investment Management’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-406,730	Closed	-$11M	–	12
2015 Q4	$11M	Buy	+406,730	New	+$10.5M	7.43%	4

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Summitview Investment Management's MR Position: Q1 2016 in Review

Summitview Investment Management sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 406,730 shares — an estimated $11M sold.

Summitview Investment Management first reported a position in MR in Q4 2015 and held it in 1 quarter. The position peaked at $11M in Q4 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

Summitview Investment Management reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
Summitview Investment Management sold 406,730 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $11M.
Summitview Investment Management first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2015 and held it in 1 quarter.
Summitview Investment Management's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $11M in Q4 2015.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Summitview Investment Management's 13F filing for Q1 2016, filed 11 May 2016.